THERE’S BEEN WIDESPREAD INTEREST across the lab industry to news that on March 31, Uropath, LLC, won a preliminary injunction in its case to prevent the federal Centers for Medicare & Medicaid Services (CMS) from implementing an anti-markup regulation for pathology services performed at anatomic pathology (AP) condo (or pod) laboratories. However, the injunction was […]
To access this post, you must purchase The Dark Report.